Home / Aztreonam and Beta-lactamase Inhibitor / Germany
DE ATC J01DF51 · updated 2 Nov 2026
Aztreonam and Beta-lactamase Inhibitor shortage in Germany
Is there an Aztreonam and Beta-lactamase Inhibitor shortage in Germany?
Yes. As of 2 Nov 2026, 1 Aztreonam and Beta-lactamase Inhibitor product is reported short in Germany, the first since 17 Jun 2026. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Italy, Spain. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Emblaveo | Pfizer Europe MA EEIG | 17 Jun 2026 | 31 Dec 2026 | Manufacturing problem Unzureichende Produktionskapazitäten |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.